21 CFR Subpart A
General Provisions
June 25, 2020
§
310.3
Definitions and interpretations
§
310.4
Biologics; products subject to license control
§
310.6
Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products